12:00 AM
 | 
Feb 20, 2012
 |  BC Week In Review  |  Company News  |  Deals

Endo, Jubilant Life Sciences deal

Jubilant's Jubilant Biosys Ltd. subsidiary received an undisclosed milestone payment after Endo selected a drug candidate targeting...

Read the full 62 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >